AG007UH6

1744-22-5 | 2-Benzothiazolamine,6-(trifluoromethoxy)-

AG007UH6

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	1744-22-5
Catalog Number	AG007UH6(AGN-PC-0JK747)
Chemical Name	2-Benzothiazolamine,6-(trifluoromethoxy)-
IUPAC Name	6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
InChI	InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
InChI Key	FTALBRSUTCGOEG-UHFFFAOYSA-N
MDL Number	MFCD00210213
Molecular Formula	C8H5F3N2OS
Molecular Weight	234.1983
SMILES	Nc1nc2c(s1)cc(cc2)OC(F)(F)F
UNII	7LJ087RS6F
Synonyms	2 Amino 6 trifluoromethoxybenzothiazole, 2-Amino-6-trifluoromethoxybenzothiazole, PK 26124, PK-26124, PK26124, Rilutek, Riluzole, RP 54274, RP-54274, RP54274, riluzole, 1744-22-5, Rilutek, 2-Amino-6-(trifluoromethoxy)benzothiazole, 6-(trifluoromethoxy)benzo[d]thiazol-2-amine, 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine, RP-54274, Riluzolum, Riluzol, 2-amino-6-trifluoromethoxybenzothiazole, 2-amino-6-(trifluoromethoxy)benzo[d]thiazole, PK-26124, Riluzol [INN-Spanish], Riluzolum [INN-Latin], 2-Benzothiazolamine, 6-(trifluoromethoxy)-, RP 54274, UNII-7LJ087RS6F, Riluzole (Rilutek), Amino-2 trifluoromethoxy-6 benzothiazole, MLS000069369, 6-Trifluoromethoxy-benzothiazol-2-ylamine, 2-Amino-6-(trifluoromethoxy)-benzothiazole, MFCD00210213, CHEMBL744, Amino-2 trifluoromethoxy-6 benzothiazole [French], C8H5F3N2OS, SMR000058231, 2-amino-6-(trifluoromethoxyl)benzothiazole, 2-Benzothiazolamine,6-(trifluoromethoxy)-, 7LJ087RS6F, CHEBI:8863, FTALBRSUTCGOEG-UHFFFAOYSA-N, BENZOTHIAZOLE, 2-AMINO-6-TRIFLUOROMETHOXY-, Riluzole, 98%, 6-(trifluoromethoxy)benzothiazol-2-amine, NCGC00015882-09, Riluzole HCl, DSSTox_CID_25192, DSSTox_RID_80739, DSSTox_GSID_45192, Riluzole [USAN:INN], Rilutek (TN), CAS-1744-22-5, 6-(trifluoromethoxy)benzothiazole-2-ylamine, Riluzole (JAN/USAN/INN), Riluzole, solid, Riluzole [USAN:USP:INN:BAN], Riluzole(Rilutek), BF-37, ALBB-006046, Riluzole(Rilutek)/, ZERO/001785, Prestwick-03A08, 2-Amino-6-trifluoro-methoxybenzothiazole, PubChem14501, Tocris-0768, PK 26124, 6-trifluoromethoxybenzothiazole-2-yl-amine, Opera_ID_548, Lopac-R-116, AC1L1JJL, Prestwick0_000167, Prestwick1_000167, Prestwick2_000167, Prestwick3_000167, Spectrum2_000550, Biomol-NT_000245, cid_5070, 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole, Lopac0_001064, SCHEMBL78905, BSPBio_000033, BIDD:GT0055, SPBio_000599, SPBio_001954, ACMC-209e89, AC1Q530H, BPBio1_000037, BPBio1_000837, GTPL2326, ZINC6481, DTXSID3045192, BDBM30705, CTK4D4982, Bio1_000416, Bio1_000905, Bio1_001394, HMS1773G08, HMS2089O19, HMS2094G07, HMS2233E14, HMS3263E10, HMS3371A09, HMS3657E13, Pharmakon1600-01505348, BCP02142, HY-B0211, KS-00000W6R, Tiglutik (thickened oral suspension), Tox21_110252, Tox21_501064, ABP000632, AC-730, ANW-22711, BBL013272, CCG-39528, NSC753433, NSC759823, s1614, SBB012436, STK503686, AKOS000265071, Tox21_110252_1, AN-6550, CS-2156, DB00740, KS-5231, LP01064, MCULE-9362288181, NSC-753433, NSC-759823, RP28111, 2-amino-6-trifluoromethoxy-benzothiazole, 6-trifluoromethoxy-2-amino-benzothiazole, NCGC00015882-01, NCGC00015882-02, NCGC00015882-03, NCGC00015882-04, NCGC00015882-05, NCGC00015882-06, NCGC00015882-07, NCGC00015882-08, NCGC00015882-10, NCGC00015882-11, NCGC00015882-12, NCGC00015882-13, NCGC00015882-15, NCGC00023141-02, NCGC00023141-04, NCGC00023141-05, NCGC00023141-06, NCGC00261749-01, 2-Amino-6-trifluoro- methoxybenzothiazole, 4CA-1092, 6-(trifluoromethoxy)-2-aminobenzothiazole, 6-trifluoromethoxybenzo[d]thiazol-2-amine, AJ-08278, AK-59567, BC219019, CJ-00110, LS-40688, SC-18839, SC-64630, ST038494, ST068834, ZB000641, SBI-0051034.P002, 2-Amino-6-(Trifluoromethoxy) Benzothiazole, 6-(Trifluoromethoxy)-2-amino-benzothiazole, AB0012884, DB-030335, TR-007739, EU-0101064, FT-0082997, FT-0611194, ST24029598, SW196805-4, EN300-23782, 6-trifluoromethoxy-1,3-benzothiazol-2-ylamine, A-5766, C07937, D00775, J10184, J10441, VU0239571-11, 744R225, I01-2084, SR-01000002997-3, BRD-K21283037-001-02-5, BRD-K21283037-003-03-9, BRD-K21283037-003-06-2, F3282-0020, Z166605314, Rilutek|||Rilutor|||6-(Trifluoromethoxy)-2-benzothiazolamine, Riluzole, United States Pharmacopeia (USP) Reference Standard, rilutor, Riluzole Zentiva, Riluzole hydrochloride, Riluzole, 98% 5g, C8H5F3NOS, D0H0KB, C8-H5-F3-N-O-S, CID5070, RP54274, AC-501, ZINC00006481, 2 Amino 6 trifluoromethoxybenzothiazole, CS-O-11735, PK26124, 6-Trifluoromethoxybenzothiazol-2-ylamine, 6-(trifluoromethoxy)-2-benzothiazolamine, R-116, H090, A2423, A8513, R1174, A10795, A13951, PK-26124, RP-54274, Rilutek, Riluzole, D019782, SR-01000002997, Riluzole, 98%, a glutamate antagonist - 25G 25g,

Complexity	238
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	234.007g/mol
Formal Charge	0
Heavy Atom Count	15
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	234.196g/mol
Monoisotopic Mass	234.007g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	76.4A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	3.6

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H302-H315-H319-H335
Packing Group	Ⅲ
Precautionary statements	P261-P301+P312-P302+P352-P304+P340-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number